317 related articles for article (PubMed ID: 17591872)
1. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
[TBL] [Abstract][Full Text] [Related]
2. Impaired angiogenic response in the corneas of mice lacking osteopontin.
Fujita N; Fujita S; Okada Y; Fujita K; Kitano A; Yamanaka O; Miyamoto T; Kon S; Uede T; Rittling SR; Denhardt DT; Saika S
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):790-4. PubMed ID: 19741245
[TBL] [Abstract][Full Text] [Related]
3. Impaired angiogenic response in the cornea of mice lacking tenascin C.
Sumioka T; Fujita N; Kitano A; Okada Y; Saika S
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2462-7. PubMed ID: 21087965
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
6. Expression of fibroblast activation proteins in corneal stromal neovascularization.
Wang T; Shi W
Curr Eye Res; 2009 Feb; 34(2):112-7. PubMed ID: 19219682
[TBL] [Abstract][Full Text] [Related]
7. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
9. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
10. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
11. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
[TBL] [Abstract][Full Text] [Related]
12. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.
Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4356-64. PubMed ID: 17003426
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
[TBL] [Abstract][Full Text] [Related]
14. Emodin suppression of ocular surface inflammatory reaction.
Kitano A; Saika S; Yamanaka O; Ikeda K; Okada Y; Shirai K; Reinach PS
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5013-22. PubMed ID: 17962452
[TBL] [Abstract][Full Text] [Related]
15. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
[TBL] [Abstract][Full Text] [Related]
16. Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration.
Lu P; Li L; Mukaida N; Zhang X
Cornea; 2007 Feb; 26(2):199-206. PubMed ID: 17251813
[TBL] [Abstract][Full Text] [Related]
17. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation.
Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
19. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha.
Stannard AK; Khurana R; Evans IM; Sofra V; Holmes DI; Zachary I
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):494-502. PubMed ID: 17170373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
